San Francisco, CA, United States of America

Shonna Moodie

This inventor holds 1 USPTO granted patent. Top assignee: Metabolex, Inc.. Active years: 2009.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shonna Moodie - Innovator in Diabetes Treatment

Introduction

Shonna Moodie is a distinguished inventor based in San Francisco, CA. She has made significant contributions to the field of medical science, particularly in the diagnosis and treatment of metabolic disorders such as diabetes.

Latest Patents

Her notable invention is a patent for "Compositions and methods for diagnosing and treating diabetes, insulin resistance, and dyslipidemia." This innovation provides advanced methods for identifying modulators of AKR1C and offers techniques for diagnosing diabetes through the measurement of AKR1C or 9α, 11β-PGF in patients. This groundbreaking work addresses critical issues in the management of diabetes and related health conditions.

Career Highlights

Shonna Moodie is currently employed at Metabolex, Inc., a company focused on transforming healthcare through innovative metabolic treatments. Her work at Metabolex has positioned her as a key player in the development of therapies that can significantly impact patient outcomes.

Collaborations

Moodie collaborates with esteemed colleagues Steve Waters and Brian Edward Lavan, enhancing her research and the overall innovation capacity of her team. Their collective efforts aim to bring forth new and effective solutions to fight diabetes and improve metabolic health.

Conclusion

In summary, Shonna Moodie's contributions to the field of diabetes treatment through her patent and work at Metabolex, Inc. underscore the importance of innovation in healthcare. As she continues to push the boundaries of science, her inventions hold the potential to change lives for the better.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…